temocillin has been researched along with Disease Models, Animal in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chenouard, R; Dubée, V; Eveillard, M; Luque Paz, D; Mahieu, R; Marion, E | 1 |
| Berleur, M; Cattoir, V; Chau, F; de Lastours, V; Fantin, B; Guérin, F; Massias, L; Poujade, J | 1 |
| Alexandre, K; Caron, F; Chau, F; Etienne, M; Fantin, B; Soares, A | 1 |
| Chau, F; Couffignal, C; Fantin, B; Lepeule, R; Massias, L; Mentre, F; Rossi, B; Ruppé, E; Soubirou, JF | 1 |
| Alexandre, K; Cattoir, V; Chau, F; Fantin, B; Guérin, F; Lefort, A; Massias, L | 1 |
| Catherall, EJ; Kernutt, I; Mizen, L; Woodnutt, G | 1 |
6 other study(ies) available for temocillin and Disease Models, Animal
| Article | Year |
|---|---|
Impact of ceftriaxone and temocillin on fecal abundance of extended-spectrum β-lactamase producing Escherichia coli in a mouse model.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Ceftriaxone; Disease Models, Animal; Enterobacteriaceae; Escherichia coli; Escherichia coli Infections; Feces; Female; Humans; Male; Mice; Microbial Sensitivity Tests; Penicillins | 2021 |
Activity of fosfomycin alone or combined with temocillin in vitro and in a murine model of peritonitis due to KPC-3- or OXA-48-producing Escherichia coli.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Bacterial Proteins; beta-Lactamases; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Fosfomycin; Mice; Microbial Sensitivity Tests; Penicillins; Peritonitis | 2018 |
Temocillin breakpoints in pyelonephritis: evaluation in a murine model due to ESBL-producing Escherichia coli clinical isolates.
Topics: Administration, Intravenous; Animals; Anti-Bacterial Agents; Bacterial Load; beta-Lactamases; Colony Count, Microbial; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Female; Humans; Kidney; Mice; Mice, Inbred CBA; Microbial Sensitivity Tests; Penicillins; Pyelonephritis | 2019 |
Activity of temocillin in a murine model of urinary tract infection due to Escherichia coli producing or not producing the ESBL CTX-M-15.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Female; Imipenem; Mice, Inbred CBA; Microbial Sensitivity Tests; Penicillins; Treatment Outcome; Urinary Tract Infections | 2015 |
Activity of temocillin in a lethal murine model of infection of intra-abdominal origin due to KPC-producing Escherichia coli.
Topics: Animals; Anti-Bacterial Agents; Ascitic Fluid; Bacteremia; Bacterial Proteins; beta-Lactamases; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Female; Injections, Subcutaneous; Intraabdominal Infections; Mice; Microbial Sensitivity Tests; Penicillins; Plasma; Spleen; Survival Analysis; Treatment Outcome | 2016 |
Influence of simulated human pharmacokinetics on the efficacy of temocillin against a Klebsiella pneumoniae meningitis infection in the rabbit.
Topics: Animals; Disease Models, Animal; Half-Life; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Meningitis, Bacterial; Penicillins; Rabbits | 1989 |